Tien Lee
Company: Aardvark Therapeutics, Inc.
Job title: CEO
Seminars:
Widening the Therapeutic Index & Overcoming the Negative Class Effects of GLP Drugs Through Incretin Combination Therapy 1:45 pm
Complementary GLP treatment approaches to minimise adverse reactions Demonstrating the potential of CCK mediated gut-brain signalling for safe, effective, and additive treatment for obesity and other indications Hunger vs appetite and selection of optimal therapeutic modalitiesRead more
day: Conference Day One
Panel Discussion & Extended Q&A: Interrogating the Roadmap From Experimental to Validated – Moving Beyond GLP-1Rs into Poly-Pharmacology 3:45 pm
day: Conference Day One